Vasoactive intestinal peptide inhibits the activation of murine fibroblasts and expression of interleukin 17 receptor C. [electronic resource]
- Cell biology international Jul 2019
- 770-780 p. digital
Publication Type: Journal Article
1095-8355
10.1002/cbin.11151 doi
Actins--metabolism Animals Collagen Type III--metabolism Disease Models, Animal Fibroblasts--immunology Hydroxyproline--metabolism Lipopolysaccharides--chemistry Male Mice NIH 3T3 Cells Protein Kinase Inhibitors--pharmacology Receptors, Interleukin--immunology Receptors, Interleukin-17--immunology Respiratory Distress Syndrome--immunology Signal Transduction--drug effects Vasoactive Intestinal Peptide--pharmacology